The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer

Table 1

Clinicopathological parameters for patients ().


Clinicopathological parameter	(%)

Age (years)
≤70	50 (42.4%)
>70	68 (57.6%)
Preoperative PSA level (ng/ml)
<10	34 (28.8%)
10-20	20 (16.9%)
>10	64 (54.3%)
Gleason score
2-6	33 (28.0%)
7	30 (25.4%)
8-10	55 (46.6%)
pT stage
≤T2	71 (60.1%)
>T2	47 (39.9%)
Metastasis
Absent	75 (63.6%)
Present	43 (36.4%)
Hormone therapy
No	87 (73.7%)
Yes	31 (26.3%)
Follow-up
Alive	61 (51.7%)
Dead	25 (21.2%)
Loss	32 (27.1%)
Surgical intervention
Prostatectomy	71 (60.2%)
TURP	47 (39.8%)

Abbreviations: pT stage: pathologic tumor stage; PSA: prostate-specific antigen; TURP: Transurethral Resection of the Prostate.